Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.

Castellanos-Moreira, Raul; Gomez, Antonio; Haro, Isabel; Ruiz-Esquide, Virginia; Marsal, Sara; Sanmarti, Raimon

Castellanos-Moreira, Raul; Gomez, Antonio; Haro, Isabel; Ruiz-Esquide, Virginia; Marsal, Sara; Sanmarti, Raimon.

Afiliação

Castellanos-Moreira R; Arthritis Unit, Rheumatology Department, Hospital Clinic of Barcelona, Spain.
Gomez A; Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Haro I; Unit of Synthesis and Biomedical Applications of Peptides, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Consejo Superior de Investigaciones Científicas, Barcelona, Spain.
Ruiz-Esquide V; Arthritis Unit, Rheumatology Department, Hospital Clinic of Barcelona, Spain.
Marsal S; Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Sanmarti R; Arthritis Unit, Rheumatology Department, Hospital Clinic of Barcelona, Spain. sanmarti@clinic.cat.

Clin Exp Rheumatol ; 39(5): 1142-1143, 2021.

Article em En | MEDLINE | ID: mdl-33666163

Assuntos

Artrite Reumatoide; Abatacepte/uso terapêutico; Artrite Reumatoide/diagnóstico; Artrite Reumatoide/tratamento farmacológico; Humanos; Fator Reumatoide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google